At a glance
ClinicalIndex Comparison RecordN/ACompleted· 130 enrolled
Drug / intervention
Fibroscandevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Elastography of the Liver in Cystic Fibrosis Patients. Diagnostic and Prognostic Aspects
In Brief
A clinical study evaluating Fibroscan for Cystic Fibrosis and Liver Fibrosis. Completed, enrolled 130 participants.
Detailed Summary
The aim of the study is to find CF patients at risk for cystic fibrosis related liver disease (CFLD). Comparison of ultrasound by two modalities and biochemical markers with histological evaluation of liver biopsy if present.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCystic Fibrosis, Liver Fibrosis
Countries--
CollaboratorsKarolinska Institutet
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2012
Primary CompletionJun 2014
First PostedNov 2015
TodayJul 2026
First PostedNov 13, 2015
Enrollment StartJan 1, 2012
Primary CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 10.6 years ago
Interventions
Fibroscandevice
Ultrasound by specific wavelength developed for elastography, repeated measures according to the manufacturer's instructions.